145 related articles for article (PubMed ID: 8509222)
21. Anti-tumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. VI. Adjuvant therapy after surgery in the inhibition of liver and spleen metastases.
Gresser I; Maury C; Belardelli F
Int J Cancer; 1987 Jun; 39(6):789-92. PubMed ID: 2438237
[TBL] [Abstract][Full Text] [Related]
22. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
[TBL] [Abstract][Full Text] [Related]
23. Antitumor effect of thymosin alpha 1/interleukin-2 or thymosin alpha 1/interferon alpha,beta following cyclophosphamide in mice injected with highly metastatic Friend erythroleukemia cells.
Garaci E; Pica F; Mastino A; Palamara AT; Belardelli F; Favalli C
J Immunother Emphasis Tumor Immunol; 1993 Jan; 13(1):7-17. PubMed ID: 8435433
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness of mouse interferon alpha/beta compared to single-agent chemotherapy in increasing survival time of mice after intravenous inoculation of Friend erythroleukemia cells.
Gresser I; Maury C; Belardelli F; Maunoury MT; Machover D
J Natl Cancer Inst; 1988 Mar; 80(2):126-31. PubMed ID: 3422696
[TBL] [Abstract][Full Text] [Related]
25. Role of cytokines in GVL (ESb lymphoma) and GVHD after adoptive transfer of allogeneic T lymphocytes in mice.
Gresser I; Greco G; Santini SM; Woodrow D; Mecchia M; Parlato S; Logozzi M; Venditti M; Maunoury MT; Belardelli F
J Interferon Cytokine Res; 1998 Sep; 18(9):667-79. PubMed ID: 9781805
[TBL] [Abstract][Full Text] [Related]
26. Anti-tumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. V. Comparisons with the action of tumor necrosis factor.
Gresser I; Belardelli F; Tavernier J; Fiers W; Podo F; Federico M; Carpinelli G; Duvillard P; Prade M; Maury C
Int J Cancer; 1986 Nov; 38(5):771-8. PubMed ID: 3464571
[TBL] [Abstract][Full Text] [Related]
27. Anti-tumor effects of interleukin-2 and interleukin-1 in mice transplanted with different syngeneic tumors.
Belardelli F; Ciolli V; Testa U; Montesoro E; Bulgarini D; Proietti E; Borghi P; Sestili P; Locardi C; Peschle C
Int J Cancer; 1989 Dec; 44(6):1108-16. PubMed ID: 2606579
[TBL] [Abstract][Full Text] [Related]
28. Biologic and biochemical differences between in vitro and in vivo passaged Friend erythroleukemia cells. I. Tumorigenicity and capacity to metastasize.
Belardelli F; Ferrantini M; Maury C; Santurbano L; Gresser I
Int J Cancer; 1984 Sep; 34(3):389-95. PubMed ID: 6207117
[TBL] [Abstract][Full Text] [Related]
29. Susceptibility of Friend virus antigen-modulated erythroleukemic cells to lysis by T lymphocytes from mice with dormant Friend virus infections.
Genovesi EV; Marx PA; Wheelock EF
J Immunol; 1979 Mar; 122(3):795-800. PubMed ID: 312825
[TBL] [Abstract][Full Text] [Related]
30. Effect of mouse interferon alpha/beta on the expression of H-2 (class I) antigens and on the levels of 2'-5' oligoadenylate synthetase activity in interferon-sensitive and interferon-resistant Friend leukemia cell tumors in mice.
Locardi C; Belardelli F; Federico M; Romeo G; Affabris E; Gresser I
J Biol Regul Homeost Agents; 1987; 1(4):189-94. PubMed ID: 3332546
[TBL] [Abstract][Full Text] [Related]
31. Isolation and characterization of a metastatic Eb-like tumor variant highly responsive to interleukin (IL)-2 and to combination cytokine therapy with IL-2/IL-1 beta and IL-1 beta/interferon-alpha/beta.
Gabriele L; Proietti E; Greco G; Venditti M; Gresser I; Schirrmacher V; Von Hoegen P; Testa U; Modesti A; Cianfriglia M
Invasion Metastasis; 1993; 13(3):147-62. PubMed ID: 8112975
[TBL] [Abstract][Full Text] [Related]
32. Natural resistance in mice against Friend leukemia cells. I. Studies with in vitro passaged interferon-sensitive and interferon-resistant cell clones.
Iorio A; Neri M; Federico M; Rossi GB; Bonmassar E
Cell Immunol; 1986 Mar; 98(1):230-7. PubMed ID: 2427224
[TBL] [Abstract][Full Text] [Related]
33. 31P-nuclear magnetic resonance analysis of interferon-induced alterations of phospholipid metabolites in interferon-sensitive and interferon-resistant Friend leukemia cell tumors in mice.
Proietti E; Carpinelli G; Di Vito M; Belardelli F; Gresser I; Podo F
Cancer Res; 1986 Jun; 46(6):2849-57. PubMed ID: 2421886
[TBL] [Abstract][Full Text] [Related]
34. Immunotherapy of murine leukemia VI. Development of immunologic memory in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
Genovesi EV; Livnat D; Collins JJ
Leuk Res; 1982; 6(4):577-93. PubMed ID: 6958931
[TBL] [Abstract][Full Text] [Related]
35. Microvascular injury in pathogenesis of interferon-induced necrosis of subcutaneous tumors in mice.
Dvorak HF; Gresser I
J Natl Cancer Inst; 1989 Apr; 81(7):497-502. PubMed ID: 2921774
[TBL] [Abstract][Full Text] [Related]
36. Antitumor activity of recombinant adenoviral vectors expressing murine IFN-alpha in mice injected with metastatic IFN-resistant tumor cells.
Santodonato L; Ferrantini M; Palombo F; Aurisicchio L; Delmastro P; La Monica N; Di Marco S; Ciliberto G; Du MX; Taylor MW; Belardelli F
Cancer Gene Ther; 2001 Jan; 8(1):63-72. PubMed ID: 11219495
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-1 beta induces tumor necrosis and early morphologic and metabolic changes in transplantable mouse tumors. Similarities with the anti-tumor effects of tumor necrosis factor alpha or beta.
Belardelli F; Proietti E; Ciolli V; Sestili P; Carpinelli G; Di Vito M; Ferretti A; Woodrow D; Boraschi D; Podo F
Int J Cancer; 1989 Jul; 44(1):116-23. PubMed ID: 2787294
[TBL] [Abstract][Full Text] [Related]
38. Acute rejection of interferon-treated leukemia cells injected into lethally irradiated syngeneic mice.
Neri M; Zei T; Tentori L; Bonmassar E; Affabris E; Iorio AM
Nat Immun; 1993; 12(6):302-15. PubMed ID: 7505668
[TBL] [Abstract][Full Text] [Related]
39. Role of endogenous alpha/beta interferon in the selection of virus nonproducer Friend leukemia cells after serial intraperitoneal passages in syngeneic mice.
Ferrantini M; Belardelli F; Locardi C
J Virol; 1988 Feb; 62(2):600-5. PubMed ID: 2447292
[TBL] [Abstract][Full Text] [Related]
40. Local and systemic antitumor response after combined therapy of mouse metastatic tumors with tumor cells expressing IFN-alpha and HSVtk: perspectives for the generation of cancer vaccines.
Santodonato L; D'Agostino G; Santini SM; Carlei D; Musiani P; Modesti A; Signorelli P; Belardelli F; Ferrantini M
Gene Ther; 1997 Nov; 4(11):1246-55. PubMed ID: 9425449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
